2008
DOI: 10.1016/j.acpain.2008.01.016
|View full text |Cite
|
Sign up to set email alerts
|

Oral transmucosal fentanyl citrate for the treatment of breakthrough pain: Results of a non-interventional study (NIS)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2011
2011
2016
2016

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…[17] Transmucosal fentanyl has been used in cancer pain management as an alternative route for opioid administration or as rotation strategy. [1819] INF has become available, providing an alternative analgesic that does not rely on venous access. The IN delivery of fentanyl provides rapid absorption (therapeutic levels within 2 min) and provide significant reduction in pain scores by 5 min.…”
Section: Discussionmentioning
confidence: 99%
“…[17] Transmucosal fentanyl has been used in cancer pain management as an alternative route for opioid administration or as rotation strategy. [1819] INF has become available, providing an alternative analgesic that does not rely on venous access. The IN delivery of fentanyl provides rapid absorption (therapeutic levels within 2 min) and provide significant reduction in pain scores by 5 min.…”
Section: Discussionmentioning
confidence: 99%